Berberine Reduces Neurotoxicity Related to Nonalcoholic Steatohepatitis in Rats

Antioxidant and Anti-Inflammatory Activities of Berberine in the Treatment of Diabetes Mellitus

(2014) Zheng Li et al.   Evidence-based Complementary and Alternative Medicine

Berberine inhibits dyslipidemia in C57BL/6 mice with lipopolysaccharide induced inflammation

(2014) Hong-Bo Xiao et al.   Pharmacological Reports

In vitro biological assessment of berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects

(2013) Abeer E Abd El-Wahab et al.   BMC Complementary and Alternative Medicine

Dual Inhibitors of Monoamine Oxidase and Cholinesterase for the Treatment of Alzheimer Disease

(2013) Matilde Yanez et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Alzheimer’s Disease, Cholesterol, and Statins: The Junctions of Important Metabolic Pathways

(2012) Tiago Silva et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

A comparative study on the hepatoprotective action of bear bile and coptidis rhizoma aqueous extract on experimental liver fibrosis in rats

(2012) Ning Wang et al.   BMC Complementary and Alternative Medicine

Nitric Oxide: Target for Therapeutic Strategies in Alzheimers Disease

(2012) A. P. Fernandez et al.   CURRENT PHARMACEUTICAL DESIGN

Tumor Necrosis Factor and Alzheimer's Disease: A Cause and Consequence Relationship

(2012) Vivek Sharma et al.   KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY

Retinol Binding Protein-4 Circulating Levels Were Higher in Nonalcoholic Fatty Liver Disease Vs. Histologically Normal Liver From Morbidly Obese Women

(2012) Ximena Terra et al.   Obesity

Molecular Basis of Inhibitory Activities of Berberine against Pathogenic Enzymes in Alzheimer's Disease

(2012) Hong-Fang Ji et al.   TheScientificWorldJOURNAL

Decrease in the production of beta-amyloid by berberine inhibition of the expression of beta-secretase in HEK293 cells

(2011) Feiqi Zhu et al.   BMC NEUROSCIENCE

Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction

(2011) Doaa A. Ghareeb et al.   METABOLIC BRAIN DISEASE

Linking lipids to Alzheimer's disease: cholesterol and beyond

(2011) Gilbert Di Paolo et al.   NATURE REVIEWS NEUROSCIENCE

Berberine derivatives, with substituted amino groups linked at the 9-position, as inhibitors of acetylcholinesterase/butyrylcholinesterase

(2010) Ling Huang et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study

(2010) E. M. C. Schrijvers et al.   NEUROLOGY

Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation

(2008) Crystal M. Cordes et al.   BIOCHEMICAL PHARMACOLOGY

Combination of simvastatin with berberine improves the lipid-lowering efficacy

(2008) Wei-Jia Kong et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production

(2007) Huaqi Xiong et al.   NEUROBIOLOGY OF DISEASE